← Back to Search

Behavioural Intervention

CP1 device for Near-sightedness

N/A
Waitlist Available
Led By Arkady Selenow, OD
Research Sponsored by Kubota Vision Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

This trial will compare the effects of a new light-based therapy device to no treatment at all in slowing the progression of myopia (nearsightedness).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Central axial length
Cycloplegic refraction

Trial Design

2Treatment groups
Active Control
Group I: ControlActive Control1 Intervention
Group II: CP1 deviceActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Kubota Vision Inc.Lead Sponsor
19 Previous Clinical Trials
2,191 Total Patients Enrolled
Arkady Selenow, ODPrincipal InvestigatorManhattan Vision Associates/Institute of Vision Research
2 Previous Clinical Trials
38 Total Patients Enrolled
~15 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top